Dilip Shanghvi

Place

• Now
  27th
• Last week
  26th
• Two weeks ago
  26th
• Three weeks ago
  28th

Dilip Shanghvi, born on October 1, 1955, in Amreli, Gujarat, India, is a prominent Indian billionaire entrepreneur and the founder of Sun Pharmaceutical Industries Limited, India's largest pharmaceutical company and one of the largest in the world. Dilip Shanghvi is recognized for his significant contributions to the pharmaceutical industry and his entrepreneurial success in building Sun Pharma into a global pharmaceutical powerhouse.

Shanghvi founded Sun Pharma in 1983 with a vision to make quality medications affordable and accessible to patients worldwide. Under his leadership as Managing Director, Sun Pharma has grown through strategic acquisitions, research and development initiatives, and global expansion.

Sun Pharma specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generic medications, specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). The company's products cover therapeutic areas such as cardiology, psychiatry, neurology, dermatology, and oncology, catering to diverse medical needs globally.

Dilip Shanghvi's strategic acumen and focus on innovation have propelled Sun Pharma to become a leader in the global pharmaceutical market. The company's robust research capabilities and commitment to quality have earned it recognition for its contributions to healthcare and patient welfare.

Beyond his role at Sun Pharma, Dilip Shanghvi is actively involved in philanthropy through the Shantilal Shanghvi Foundation, which supports education, healthcare, and community development initiatives in India. His philanthropic efforts aim to improve the quality of life for underprivileged communities and promote sustainable development.

Dilip Shanghvi's entrepreneurial journey and leadership in the pharmaceutical industry highlight his influence as a transformative figure in healthcare and business in India and globally. His vision continues to drive Sun Pharma's growth and its impact on healthcare accessibility and affordability worldwide.

Share

Your involvement